She walks through how Lilly tested the combination in 367 adults with obesity or overweight, a trial she says reached 23% weight loss.
Recap by typeshit. Post by @obesitydrdannak on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
His reason: drugs like Ozempic, Mounjaro and Wegovy can slow how fast the stomach empties, which matters for anesthesia.
Dr Bae says some patients may need a higher dose for different reasons, and asks followers where they landed. A light engagement post with little new detail.
Loading…